IR@PKUHSC  > 北京大学第二临床医学院  > 妇科肿瘤中心
学科主题临床医学
Vaccination with embryonic stem cells generates effective antitumor immunity against ovarian cancer
Zhang, Zujuan; Chen, Xinhua; Chang, Xiaohong; Ye, Xue; Li, Yi; Cui, Heng
关键词Ovarian Cancer Embryonic Stem Cell Antitumor Immunity Immunotherapy Cancer Vaccine
刊名INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
2013
DOI10.3892/ijmm.2012.1195
31期:1页:147-153
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Medicine, Research & Experimental
研究领域[WOS]Research & Experimental Medicine
关键词[WOS]BREAST-CANCER ; MOUSE MODEL ; CHEMOTHERAPY ; EXPRESSION ; VACCINES ; GROWTH
英文摘要

To date, only a few studies have suggested that human embryonic stem cells (hESCs) might effectively immunize against colon and lung cancer. The purpose of this study was to investigate the therapeutic potential of hESCs as a vaccine to induce widespread antitumor effects in different animal models and various types of cancer. C57BL/6 mice with 1138 ovarian cancer cell and Fischer 344 rats with NuTu-19 ovarian cancer cell models were used. Fifty-four mice were divided into six groups with nine mice in each group. Each mouse was immunized with pre-inactivated hESCs (H9) or mouse embryonic stem cells (mESCs; IVP-ESI) or ID8 or phosphate-buffered saline (PBS). Twenty-four rats were divided into four groups with six rats in each group, each rat immunized with pre-inactivated hESCs (H9) or NuTu-19 or PBS. After the vaccination, each mouse was challenged with live ID8 cells subcutaneously, and each rat was challenged with live NuTu-19 cells intraperitoneally. We discovered that vaccination of mice with the hESC line H9 and the m ESC line IVP-ESI generated consistent cellular and humoral immune responses against 1138 ovarian cancer. H9 and IVP-ESI vaccinated mice obtained antitumor immune protection, and H9 vaccinated rats had the longest survival time and least distant metastases. No evidence of side-effects was observed. We also compared the immunogenicity against ovarian cancer between the hESC line, H9, and the mESC line, IVP-ESI, that derived from the inner cell mass in different species. We found that there were no significant differences between them. Furthermore, immunohistochemical staining revealed that several oncogenes and tumor suppressor genes, such as HER-2, C-myc, p53, and nm23, were expressed in H9, many of which were also shared by ovarian cancer. hESC vaccines can induce antitumor effects in two animal models and in ovarian cancer, indicating that the activity of the vaccine is universal, and, more importantly, it is safe.

语种英语
WOS记录号WOS:000312567000019
引用统计
被引频次:6[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/55506
专题北京大学第二临床医学院_妇科肿瘤中心
作者单位Peking Univ, Peoples Hosp, Gynecol Oncol Ctr, Beijing 100044, Peoples R China
推荐引用方式
GB/T 7714
Zhang, Zujuan,Chen, Xinhua,Chang, Xiaohong,et al. Vaccination with embryonic stem cells generates effective antitumor immunity against ovarian cancer[J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE,2013,31(1):147-153.
APA Zhang, Zujuan,Chen, Xinhua,Chang, Xiaohong,Ye, Xue,Li, Yi,&Cui, Heng.(2013).Vaccination with embryonic stem cells generates effective antitumor immunity against ovarian cancer.INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE,31(1),147-153.
MLA Zhang, Zujuan,et al."Vaccination with embryonic stem cells generates effective antitumor immunity against ovarian cancer".INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 31.1(2013):147-153.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zhang, Zujuan]的文章
[Chen, Xinhua]的文章
[Chang, Xiaohong]的文章
百度学术
百度学术中相似的文章
[Zhang, Zujuan]的文章
[Chen, Xinhua]的文章
[Chang, Xiaohong]的文章
必应学术
必应学术中相似的文章
[Zhang, Zujuan]的文章
[Chen, Xinhua]的文章
[Chang, Xiaohong]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。